|
1
|
Lantz PM and Booth KM: The social
construction of the breast cancer epidemic. Soc Sci Med.
46:907–918. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vallance JK, Courneya KS, Plotnikoff RC
and Mackey JR: Analyzing theoretical mechanisms of physical
activity behavior change in breast cancer survivors: Results from
the activity promotion (ACTION) trial. Ann Behav Med. 35:150–158.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
DeSantis CE, Bray F, Ferlay J,
Lortet-Tieulent J, Anderson BO and Jemal A: International variation
in female breast cancer incidence and mortality rates. Cancer
Epidemiol Biomarkers Prev. 24:1495–1506. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kitamura T, Qian BZ, Soong D, Cassetta L,
Noy R, Sugano G, Kato Y, Li J and Pollard JW: CCL2-induced
chemokine cascade promotes breast cancer metastasis by enhancing
retention of metastasis-associated macrophages. J Exp Med.
212:1043–1059. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chee W, Lee Y, Im EO, Chee E, Tsai HM,
Nishigaki M, Yeo SA, Schapira MM and Mao JJ: A culturally tailored
Internet cancer support group for Asian American breast cancer
survivors: A randomized controlled pilot intervention study. J
Telemed Telecare. 23:618–626. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Stuart-Harris R, Dahlstrom JE, Gupta R,
Zhang Y, Craft P and Shadbolt B: Recurrence in early breast cancer:
Analysis of data from 3,765 Australian women treated between 1997
and 2015. Breast. 44:153–159. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rouzier R, Perou CM, Symmans WF, Ibrahim
N, Cristofanilli M, Anderson K, Hess KR, Stec J, Ayers M, Wagner P,
et al: Breast cancer molecular subtypes respond differently to
preoperative chemotherapy. Clin Cancer Res. 11:5678–5685. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Edenfield J, Schammel C, Collins J,
Schammel D and Edenfield WJ: Metaplastic breast cancer: Molecular
typing and identification of potential targeted therapies at a
single institution. Clin Breast Cancer. 17:e1–e10. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chou R, Cuevas C, Fu R, Devine B, Wasson
N, Ginsburg A, Zakher B, Pappas M, Graham E and Sullivan SD:
Imaging techniques for the diagnosis of hepatocellular carcinoma: A
systematic review and meta-analysis. Ann Intern Med. 162:697–711.
2015. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ohuchi N, Suzuki A, Sobue T, Kawai M,
Yamamoto S, Zheng YF, Shiono YN, Saito H, Kuriyama S, Tohno E, et
al J-START investigator groups, : Sensitivity and specificity of
mammography and adjunctive ultrasonography to screen for breast
cancer in the Japan Strategic Anti-cancer Randomized Trial
(J-START): A randomised controlled trial. Lancet. 387:341–348.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Brem RF, Lenihan MJ, Lieberman J and
Torrente J: Screening breast ultrasound: Past, present, and future.
AJR Am J Roentgenol. 204:234–240. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang Q, Luo Y and Zhang Q: Breast
ultrasound image segmentation: A survey. Int J CARS. 12:493–507.
2017. View Article : Google Scholar
|
|
13
|
Xia W, Yan Z and Gao X: Volume fractions
of DCE-MRI parameter as early predictor of histologic response in
soft tissue sarcoma: A feasibility study. Eur J Radiol. 95:228–235.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Perera M, Papa N, Christidis D, Wetherell
D, Hofman MS, Murphy DG, Bolton D and Lawrentschuk N: Sensitivity,
specificity, and predictors of positive 68Ga-prostate-specific
membrane antigen positron emission tomography in advanced prostate
cancer: a systematic review and meta-analysis. Eur Urol.
70:926–937. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao H, Zou L, Geng X and Zheng S:
Limitations of mammography in the diagnosis of breast diseases
compared with ultrasonography: A single-center retrospective
analysis of 274 cases. Eur J Med Res. 20:492015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mavaddat N, Michailidou K, Dennis J, Lush
M, Fachal L, Lee A, Tyrer JP, Chen TH, Wang Q, Bolla MK, et al
ABCTB Investigators; kConFab/AOCS Investigators; NBCS
Collaborators, : Polygenic risk scores for prediction of breast
cancer and breast cancer subtypes. Am J Hum Genet. 104:21–34. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Christiansen P, Bjerre K, Ejlertsen B,
Jensen MB, Rasmussen BB, Lænkholm AV, Kroman N, Ewertz M, Offersen
B, Toftdahl DB, et al Danish Breast Cancer Cooperative Group, :
Mortality rates among early-stage hormone receptor-positive breast
cancer patients: A population-based cohort study in Denmark. J Natl
Cancer Inst. 103:1363–1372. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jafari SH, Saadatpour Z, Salmaninejad A,
Momeni F, Mokhtari M, Nahand JS, Rahmati M, Mirzaei H and Kianmehr
M: Breast cancer diagnosis: Imaging techniques and biochemical
markers. J Cell Physiol. 233:5200–5213. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Montes de Oca R, Gurard-Levin ZA, Berger
F, Rehman H, Martel E, Corpet A, de Koning L, Vassias I, Wilson LO,
Meseure D, et al: The histone chaperone HJURP is a new independent
prognostic marker for luminal A breast carcinoma. Mol Oncol.
9:657–674. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen L, Li CI, Tang MT, Porter P, Hill DA,
Wiggins CL and Cook LS: Reproductive factors and risk of luminal,
HER2-overexpressing, and triple-negative breast cancer among
multiethnic women. Cancer Epidemiol Biomarkers Prev. 25:1297–1304.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gallardo A, Garcia-Valdecasas B, Murata P,
Teran R, Lopez L, Barnadas A and Lerma E: Inverse relationship
between Ki67 and survival in early luminal breast cancer:
Confirmation in a multivariate analysis. Breast Cancer Res Treat.
167:31–37. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Adriaenssens E, Vanhecke E, Saule P,
Mougel A, Page A, Romon R, Nurcombe V, Le Bourhis X and Hondermarck
H: Nerve growth factor is a potential therapeutic target in breast
cancer. Cancer Res. 68:346–351. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li H, Zhu Y, Burnside ES, Huang E, Drukker
K, Hoadley KA, Fan C, Conzen SD, Zuley M, Net JM, et al:
Quantitative MRI radiomics in the prediction of molecular
classifications of breast cancer subtypes in the TCGA/TCIA data
set. NPJ Breast Cancer. 2:22016. View Article : Google Scholar
|
|
24
|
Goffin J, Chappuis PO, Wong N and Foulkes
WD: Re: Magnetic resonance imaging and mammography in women with a
hereditary risk of breast cancer. J Natl Cancer Inst. 93:1754–1755.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shao H, Li B, Zhang X, Xiong Z, Liu Y and
Tang G: Comparison of the diagnostic efficiency for breast cancer
in Chinese women using mammography, ultrasound, MRI, and different
combinations of these imaging modalities. J Xray Sci Technol.
21:283–292. 2013.PubMed/NCBI
|
|
26
|
Shimauchi A, Jansen SA, Abe H, Jaskowiak
N, Schmidt RA and Newstead GM: Breast cancers not detected at MRI:
Review of false-negative lesions. AJR Am J Roentgenol.
194:1674–1679. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bäuerle T, Bartling S, Berger M,
Schmitt-Gräff A, Hilbig H, Kauczor HU, Delorme S and Kiessling F:
Imaging anti-angiogenic treatment response with DCE-VCT, DCE-MRI
and DWI in an animal model of breast cancer bone metastasis. Eur J
Radiol. 73:280–287. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kriege M, Brekelmans CT, Boetes C, Besnard
PE, Zonderland HM, Obdeijn IM, Manoliu RA, Kok T, Peterse H,
Tilanus-Linthorst MM, et al Magnetic Resonance Imaging Screening
Study Group, : Efficacy of MRI and mammography for breast-cancer
screening in women with a familial or genetic predisposition. N
Engl J Med. 351:427–437. 2004. View Article : Google Scholar : PubMed/NCBI
|
